International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2019 - Volume 23, Number 4
View All Articles in Issue

Page(s): 315

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, candesartan cilexetil, hypertension, high blood pressure, antihypertensive agent, racemic mixture

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Allen Loyd V Jr	Jul/Aug 2019 Pg. 315
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Candesartan Cilexetil 8 mg Liquid-Filled Capsules Allen Loyd V Jr	Mar/Apr 2017 Pg. 147
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 232
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Candesartan Cilexitil 1 mg/mL Syrup Allen Loyd V Jr	May/Jun 2022 Pg. 234
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Oral Liquid Vehicles, Featured Excipient: Allen Loyd V Jr	Jan/Feb 2001 Pg. 65-67
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Featured Excipient: Plasticizers Allen Loyd V Jr	Mar/Apr 2003 Pg. 145-148
Valsartan 4 mg/mL in Syrup NF Allen Loyd V Jr	Mar/Apr 2020 Pg. 139
Featured Excipient: Flavor Enhancing Agents Allen Loyd V Jr	Jan/Feb 2003 Pg. 48-50
Transdermal Delivery of Nisoldipine: Refinement of Vehicles El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A	Mar/Apr 2015 Pg. 152-160
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Fonseca Simonne C	Nov/Dec 2005 Pg. 456-461
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Return to Top